BioXcel Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.About BTAI
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions.
BTAI Key Statistics
Stock Snapshot
As of today, BioXcel Therapeutics(BTAI) shares are valued at $1.14. The company's market cap stands at 31M, with a P/E ratio of -0.16.
On 2026-05-18, BioXcel Therapeutics(BTAI) stock opened at $1.17, reached a high of —, and a low of —.
The BioXcel Therapeutics(BTAI)'s current trading volume is 2.37K, compared to an average daily volume of 575.72K.
During the past year, BioXcel Therapeutics(BTAI) stock moved between $1.01 at its lowest and $8.08 at its peak.
During the past year, BioXcel Therapeutics(BTAI) stock moved between $1.01 at its lowest and $8.08 at its peak.
BTAI News
BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $1.50 per share versus the Zacks Consensus Estimate of a loss of $2.72. This compares to los...
Reports Q1 revenue $206,000, consensus $381,490. “The first quarter was marked by tremendous progress, achieving a major regulatory milestone and developing the...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.